NO20076361L - Nye regimer for kontrollerte medikament leveringsinnretninger for befruktningshindring - Google Patents

Nye regimer for kontrollerte medikament leveringsinnretninger for befruktningshindring

Info

Publication number
NO20076361L
NO20076361L NO20076361A NO20076361A NO20076361L NO 20076361 L NO20076361 L NO 20076361L NO 20076361 A NO20076361 A NO 20076361A NO 20076361 A NO20076361 A NO 20076361A NO 20076361 L NO20076361 L NO 20076361L
Authority
NO
Norway
Prior art keywords
contraception
drug delivery
delivery devices
controlled drug
new regimes
Prior art date
Application number
NO20076361A
Other languages
English (en)
Norwegian (no)
Inventor
Victoria Jane Davis
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2006/023383 external-priority patent/WO2007001888A2/en
Application filed by Organon Nv filed Critical Organon Nv
Publication of NO20076361L publication Critical patent/NO20076361L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20076361A 2005-06-21 2007-12-12 Nye regimer for kontrollerte medikament leveringsinnretninger for befruktningshindring NO20076361L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05105481 2005-06-21
PCT/US2006/023383 WO2007001888A2 (en) 2005-06-21 2006-06-16 New regimens for controlled drug delivery devices for contraception

Publications (1)

Publication Number Publication Date
NO20076361L true NO20076361L (no) 2008-03-17

Family

ID=35124442

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076361A NO20076361L (no) 2005-06-21 2007-12-12 Nye regimer for kontrollerte medikament leveringsinnretninger for befruktningshindring

Country Status (9)

Country Link
US (1) US20080207571A1 (es)
JP (1) JP2009539759A (es)
CN (1) CN101237836A (es)
AR (1) AR055339A1 (es)
IL (1) IL188129A0 (es)
NO (1) NO20076361L (es)
PE (1) PE20070119A1 (es)
RU (1) RU2408332C2 (es)
TW (1) TW200744610A (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) * 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) * 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
WO2008007098A2 (en) * 2006-07-12 2008-01-17 Controlled Therapeutics (Scotland) Ltd. Drug delivery polymer with hydrochloride salt of clindamycin
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3062211A (en) * 1958-09-03 1962-11-06 Henry W Walden Irrigating or spraying devices
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
EP0180264A1 (en) * 1984-10-12 1986-05-07 Akzo N.V. Release system for two or more active substances
US5010055A (en) * 1986-06-24 1991-04-23 The General Hospital Corporation Use of EGF to reverse the contraceptive activity of MIS
US5185374A (en) * 1988-05-11 1993-02-09 K.K. Ueno Seiyaku Oyo Kenkyujo Use of 15-ketoprostaglandin E or F compounds for uterine contraction
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US6479475B1 (en) * 1996-07-26 2002-11-12 Wyeth Oral contraceptive
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
US7017513B2 (en) * 2001-08-08 2006-03-28 Harry Giewercer Dosage reminder device and medication carton
US20060079491A1 (en) * 2004-10-08 2006-04-13 Andreas Sachse Method of female hormonal contraception using a fixed extended cycle hormonal preparation containing dienogest and ethinyl estradiol

Also Published As

Publication number Publication date
PE20070119A1 (es) 2007-02-09
CN101237836A (zh) 2008-08-06
TW200744610A (en) 2007-12-16
RU2408332C2 (ru) 2011-01-10
IL188129A0 (en) 2008-03-20
US20080207571A1 (en) 2008-08-28
RU2008102121A (ru) 2009-07-27
JP2009539759A (ja) 2009-11-19
AR055339A1 (es) 2007-08-22

Similar Documents

Publication Publication Date Title
RS53128B (en) Extending the time of disease progression or survival in patients with ovarian cancers using PERTUZUMAB
DE602004019053D1 (de) Titrationsdosierschema für kontrolliert freigesetztes tramadol
NO20076361L (no) Nye regimer for kontrollerte medikament leveringsinnretninger for befruktningshindring
GB2491526A (en) Method and apparatus for manufacturing an implant
MXPA05006670A (es) Administracion de capsaicinoides.
RS54655B1 (en) DOSAGE MODE FOR USE OF CD19XCD3 Bispecific Antibody
AR054525A1 (es) Composiciones y metodos para eltratamiento de sintomas relacionados con el ciclo
TW200630326A (en) Chemical compounds
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
GEP20115357B (en) Amine derivatives
ATE511392T1 (de) Verzögert freigesetzte orale dosierungsformen eines prodrugs von r-baclofen und behandlungsverfahren damit
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
TW200744672A (en) Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily
CL2007002875A1 (es) Composicion farmaceutica recubierta por una pelicula que comprende capecitabina y al menos un disgregante, util en el tratamiento del cancer para pacientes que tienen dificultad para tragar las formas de dosificacion solidas orales.
HK1097774A1 (en) Stable pharmaceutical composition comprising linezolid from iv
RU2007122391A (ru) S-миртазапин для лечения приливов
NZ628513A (en) Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
DK2178513T3 (da) Sammensætninger i tabletform indeholdende atazanavir
JOP20210004A1 (ar) عوامل تحلّل مستقبلات الإستروجين الانتقائية
MX2020011817A (es) Metodos para tratar el linfoma.
ATE347358T1 (de) Schwimmende orale formulierungen mit kontrollierter freisetzung von betain
ATE554753T1 (de) 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia
DK1643999T3 (da) Pyridoxamin til anvendelse ved behandlingen af diabetisk nefropati ved type 2-diabetes
PT1603584E (pt) Aplidina para o tratamento de mieloma múltiplo

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application